EPIDRI 6% 2.1 MG
RACEMIC EPINEPHRINE HYDROCHLORIDE : 2.1 MG · DIN 00154644 · PASCAL INTERNATIONAL CORPORATION
Health Canada status: CANCELLED POST MARKET
What is EPIDRI 6%?
EPIDRI 6% 2.1 MG contains RACEMIC EPINEPHRINE HYDROCHLORIDE : 2.1 MG. It is listed in the Health Canada Drug Product Database under DIN 00154644, held by PASCAL INTERNATIONAL CORPORATION, supplied as PELLET (DENTAL) for DENTAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Jun-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00154644 |
|---|---|
| Brand name | EPIDRI 6% |
| Generic / active ingredient | RACEMIC EPINEPHRINE HYDROCHLORIDE : 2.1 MG |
| Manufacturer | PASCAL INTERNATIONAL CORPORATION |
| Strength | 2.1 MG |
| Dosage form | PELLET (DENTAL) |
| Route of administration | DENTAL |
| Schedule | Ethical |
| ATC code | A01AD01 EPINEPHRINE |
| AHFS class | 34:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Jun-2005 |
| Original market date | 1951-12-31 00:00:00 |
Is EPINEPHRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A01AD01 EPINEPHRINE. 0 of 21 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CORD NO2 GINGIVAL RETRACTION | 0.5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 00479306 |
| CORD NO3 | 0.5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 02240391 |
| COTTON COIL | 3 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 00479322 |
| CROWN PAK RETRACTION CORD | 0.5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 02240392 |
| GINGI PAK CORD | 0.5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 02240393 |
| GINGI PAK CORD NO 1 | .5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 00775142 |
| GINGI PAK DARK BRAID #1 | .5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 00539333 |
| GINGI PAK DARK BRAID #O | .5 MG / 2.54 CM | CORD | GINGI-PAK LABS, DIVISION OF BELPORT CO., INC. | CANCELLED POST MARKET | DIN 00811483 |
| GINGIYARN W EPINEPH NO1 0.55MG/2.5CM | .55 MG / 2.5 CM | CORD | VAN R DENTAL PRODUCTS INC. | CANCELLED POST MARKET | DIN 00572705 |
| GINGIYARN W EPINEPH NO2 1.05MG/2.5CM | 1.05 MG / 2.5 CM | CORD | VAN R DENTAL PRODUCTS INC. | CANCELLED POST MARKET | DIN 00572691 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.